Sorbent augmented hemodialysis systems: Are we there yet?

Journal of the American Society of Nephrology

Volumn 21, Issue 2, 2010, Pages 209-211

  Winchester, James F ^a   Ronco, Claudio ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; UREA; UREMIC TOXIN; CHARCOAL;

ACUTE KIDNEY FAILURE; BIOCOMPATIBILITY; DIALYSATE; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MOLECULAR WEIGHT; NONHUMAN; NOTE; PRIORITY JOURNAL; SOLUTE; UNITED STATES; ARTICLE; HEMODIAFILTRATION; MATERIALS TESTING; METHODOLOGY; RENAL REPLACEMENT THERAPY;

CHARCOAL; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; MATERIALS TESTING; RENAL DIALYSIS;

EID: 77949407843     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008080899     Document Type: Note

References (22)

1. Davenport A, Gura V, Ronco C, Beizai M, Ezon C, Rambod E: A wearable haemodialysis device for patients with end-stage renal failure: A pilot study. Lancet 370: 2005-2010, 2007
2. Kolff WJ, Jacobsen S, Stephen RL, Rose D: Towards a wearable artificial kidney. Kidney Int Suppl S300-S304, 1976
3. Meyer TW, Hostetter TH: Uremia. N Engl J Med 357: 1316-1325, 2007
4. US Renal Data System: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007
5. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, DelmezJA, DepnerTA, DwyerJT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
6. Carrero JJ, Yilmaz MI, Lindholm B, Sten-vinkel P: Cytokine dysregulation in chronic kidney disease: How can we treat it? Blood Purif 26: 291-299, 2008
7. Schiffer E, Mischak H, Vanholder RC: Exploring the uremic toxins using proteomic technologies. Contrib Nephrol 160: 159-171, 2008
8. Marinez de Francisco AL, Ghezzi PM, Bren-dolan A, Fiorini F, La Greca G, Ronco C, Arias M, Gervasio R, Tetta C: Hemodiafiltra-tion with online regeneration of the ultrafil-trate. Kidney Int 58[Suppl 76]: S66-S71, 2000
9. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W: A comparison of on-line he-modiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 11: 2344-2350, 2000
10. Takenaka T, Itaya Y, Tsuchiya Y, Kobayashi K, Suzuki H: Fitness of biocompatible high-flux hemodiafiltration for dialysis-related amyloidosis. Blood Purif 19: 10-14, 2001
11. Meyer TW, Peattie JW, Miller JD, Dinh DC, Recht NS, Walther JL, Hostetter TH: Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 18: 868-874, 2007
12. Samtleben W, Gurland HJ, Lysaght MJ, Winchester JF: Plasma exchange and hemoper-fusion. In: Replacement of Renal Function by Dialysis, edited by Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (Editor in Chief), Dordrecht, Kluwer Academic Publishers, 1996, pp 472-500
13. Ronco C, Brendolan A, Winchester JF, Golds E, Clemmer J, Polaschegg HD, Muller TE, La Greca G, Levin N: First clinical experience with an adjunctive hemoperfusion device designed specifically to remove /32-mi-croglobulin in hemodialysis. Blood Purif 19: 260-263, 2001 (Pubitemid 32041365)
14. Inagi R, Miyata T: Oxidative protein damage with carbohydrates and lipids in uremia: 'Car-bonyl stress.' Blood Purif 17: 95-98, 1999
15. Zethelius B, Berglund L, Sundströ m J, In-gelsson E, Basu S, Larsson A, Venge P, Arnlö v J: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358: 2107-2116, 2008
16. Uhlin F, Fridolin I, Lindberg L-G, Magnusson M: Estimating total urea removal and protein catabolic rate by monitoring UV absor-bance in spent dialysate. Nephrol Dial Transplant 20: 2458-2464, 2005
17. Shapiro WB: The Allient sorbent hemodi-alysis system. In: Handbook of Dialysis Therapy, 4th Ed., edited by Nissenson AR, Fine RN, Philadelphia, Saunders, 2008, pp 512-520
18. Malik DJ, Warwick GL, Venturi M, Streat M, Hellgardt K, Hoenich N, Dale JA: Preparation of novel mesoporous carbons for the adsorption of an inflammatory cy-tokine (IL-1 beta). Biomaterials 25: 2933-2940, 2004
19. Winchester JF, Silberzweig J, Ronco C, Kuntsevich V, Levine D, Parker T, Kellum JA, Salsberg JA, Quartararo P, Levin NW: Sorbents in acute renal failure and end stage renal disease: Middle molecule and cy-tokine removal. Blood Purif 22: 73-77, 2004
20. Homma N, Gejyo F, Hasegawa S, Tera-mura T, Ei I, Maruyama H, Arakawa M: Effects of a new adsorbent column for removing beta-2-microglobulin from circulating blood of dialysis patients. Contrib Nephrol 112: 164-171, 1995
21. Ronco C, Brendolan A, Lonnemann G, Bel-lomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 30: 1250-1255, 2002
22. Piccolomini F, Wratten ML, Sereni L, Balestreri E, Donadio E, Felicioli A, Felicioli R, Donadio C: Effects of the incubation in vitro with sor-bents on serum proteomic pattern and cyto-kine concentration in cancer patients during chemotherapy: Preliminary results. Biomed Pharmacother 60: 463-467, 2006